Clinical Physiology of Circulation

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Biomarkers as predictors of early recurrence of atrial fibrillation after radiofrequency ablation

Authors: Akildzhonov F.R., Asymbekova E.U., Kamardinov D.Kh., Sherstyannikova O.M., Songurov R.N.

Company:
Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, 121552, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

DOI: https://doi.org/10.24022/1814- 6910-2021-18-2-139-148

UDC: 616.125-008.313-073.43-089

Link: Clinical Physiology of Blood Circulaiton. 2021; 2 (18): 139-148

Quote as: Akildzhonov F.R., Asymbekova E.U., Kamardinov D.Kh., Sherstyannikova O.M., Songurov R.N. Biomarkers as predictors of early recurrence of atrial fibrillation after radiofrequency ablation. Clinical Physiology of Circulation. 2021; 18 (2): 139–48 (in Russ.). DOI: 10.24022/1814-6910-2021-18-2-139-148

Received / Accepted:  06.04.2021 / 01.05.2021

Download
Full text:  

Abstract

A growing body of evidence supports the strong predictive value of biomarkers in cardiovascular disease. Thus, despite the convincing results of large multicenter randomized studies, many aspects of the interaction of biomarkers remain unclear and require further research. To date, it is known that some biomarkers reflect the pathophysiological development of atrial fibrillation (AF), while others can be used as markers to calculate the estimated risk, and the study of biomarkers will help in a deeper understanding of the pathophysiology of AF, the development of a treatment strategy, and possibly even early detection of the disease. Vigorous research on promising new biomarkers is ongoing. Nevertheless, biomarkers are gaining increasing clinical significance and may play a key role in the future in refining the assessment of the clinical risk of AF recurrence after catheter ablation. This review presents current biomarker data as predictors of early AF recurrence after radiofrequency ablation, although the pathophysiology of many biomarkers remains unclear. Keywords: radiofrequency ablation, atrial fibrillation, natriuretic peptides.

About Authors

  • Firdavsdzhon R. Akildzhonov, Resident Physician; ORCID
  • El’mira U. Asymbekova, Dr. Med. Sc., Leading Researcher; ORCID
  • Dzhamshed Kh. Kamardinov, Dr. Med. Sc., Cardiologist; ORCID
  • Ol’ga M. Sherstyannikova, Cand. Med. Sc., Researcher; ORCID
  • Rashid N. Songurov, Cardiologist; ORCID

 If you found mistakes, select text and press Alt+A